Andrew Schiermeier
Director Ejecutivo en AvenCell Therapeutics, Inc. .
Cargos activos de Andrew Schiermeier
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Kynan Pharmaceuticals | Director/Miembro de la Junta | - | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Miembro de la Junta | 01/08/2021 | - |
| Director Ejecutivo | 01/08/2021 | - | |
Regel Therapeutics Inc.
 Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Director/Miembro de la Junta | - | - |
Historial de carrera de Andrew Schiermeier
Antiguos cargos conocidos de Andrew Schiermeier.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Director de Operaciones | - | 21/06/2021 |
| Corporate Officer/Principal | 01/04/2018 | - | |
| MERCK KGAA | Corporate Officer/Principal | 01/05/2013 | 01/01/2016 |
| AURA BIOSCIENCES, INC. | Director de Operaciones | 01/01/2011 | 01/05/2013 |
Formación de Andrew Schiermeier.
| College des Ingenieurs | Masters Business Admin |
| Harvard University | Doctorate Degree |
| Stanford University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Francia | 2 |
| Alemania | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| MERCK KGAA | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Kynan Pharmaceuticals | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
Regel Therapeutics Inc.
Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Schiermeier
- Experiencia
